Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer
The Long Run with Luke Timmerman - Un pódcast de Timmerman Report
Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.
The Long Run with Luke Timmerman - Un pódcast de Timmerman Report
Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.
